Endocrine, metabolic & immune disorders, drug targets
Medienart: |
E-Zeitschrift |
---|
Erscheinungsjahr: |
2006- |
---|---|
Erschienen: |
Sharjah: Bentham Science Publ. ; 2006- 6.2006 - |
Weitere Ausgaben: |
Erscheint auch als Druck-Ausgabe: Endocrine, metabolic & immune disorders, drug targets |
---|
Sprache: |
Englisch |
---|
Weiterer Titel: |
Endocrine, metabolic and immune disorders, drug targets |
---|---|
Vorheriger Titel: |
Current drug targets. Immune, endocrine & metabolic disorders |
Links: |
www.bibliothek.uni-regensburg.de |
---|
ISSN: |
---|
Themen: |
---|
Anmerkungen: |
Gesehen am 15.04.2024 |
---|
Umfang: |
Online-Ressource |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
518958558 |
---|
LEADER | 01000cas a2200265 4500 | ||
---|---|---|---|
001 | 518958558 | ||
003 | DE-627 | ||
005 | 20240415153812.0 | ||
007 | cr ||||||||||| | ||
008 | 061019c20069999ts q| p|o 0 |0eng c | ||
016 | 7 | |a 981502652 |2 DE-101 | |
016 | 7 | |a 2254157-3 |2 DE-600 | |
022 | |a 2212-3873 | ||
035 | |a (DE-627)518958558 | ||
035 | |a (DE-576)273890999 | ||
035 | |a (DE-599)ZDB2254157-3 | ||
035 | |a (OCoLC)1164174388 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
044 | |c XB-AE | ||
084 | |a PHARM |q DE-84 |2 fid | ||
210 | 1 | 0 | |a Endocr Metab Immune Disord Drug Targets |
245 | 1 | 0 | |a Endocrine, metabolic & immune disorders, drug targets |
246 | 3 | 3 | |a Endocrine, metabolic and immune disorders, drug targets |
264 | 3 | 1 | |a Sharjah |b Bentham Science Publ. |c 2006- |
300 | |a Online-Ressource | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
362 | 0 | |a 6.2006 - | |
363 | 0 | 1 | |a 6 |i 2006 |
500 | |a Gesehen am 15.04.2024 | ||
655 | 7 | |a Zeitschrift |0 (DE-588)4067488-5 |0 (DE-627)10454466X |0 (DE-576)20917000X |2 gnd-content | |
776 | 1 | |x 1871-5303 | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |t Endocrine, metabolic & immune disorders, drug targets |d Sharjah : Bentham Science Publ., 2006 |w (DE-627)509757847 |w (DE-600)2228325-0 |w (DE-576)518400182 |x 1871-5303 |
780 | 0 | 0 | |i Vorg |t Current drug targets. Immune, endocrine & metabolic disorders |d Hilversum [u.a.] : Bentham Science Publ., 2001 |h Online-Ressource |w (DE-627)367170493 |w (DE-600)2114916-1 |w (DE-576)27388736X |x 1875-5917 |
856 | 4 | 0 | |u http://www.bibliothek.uni-regensburg.de/ezeit/?2254157 |x Frontdoor-Url |
856 | 4 | 0 | |u https://www.eurekaselect.com/journal/59 |x Verlag |
856 | 4 | 0 | |u https://www.ingentaconnect.com/content/ben/emiddt |x Agentur |
912 | |a ZDB-1-BEJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a ISIL_DE-84 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
912 | |a SSG-OPC-DE-84 | ||
912 | |a GBV_ILN_22 | ||
912 | |a ISIL_DE-18 | ||
912 | |a GBV_ILN_31 | ||
912 | |a ISIL_DE-27 | ||
912 | |a GBV_ILN_55 | ||
912 | |a ISIL_DE-Goe116 | ||
912 | |a GBV_ILN_65 | ||
912 | |a ISIL_DE-3 | ||
912 | |a GBV_ILN_69 | ||
912 | |a ISIL_DE-9 | ||
912 | |a GBV_ILN_209 | ||
912 | |a ISIL_DE-Pn1 | ||
912 | |a GBV_ILN_215 | ||
912 | |a ISIL_DE-Ma54 | ||
912 | |a GBV_ILN_239 | ||
912 | |a ISIL_DE-J126 | ||
912 | |a GBV_ILN_685 | ||
912 | |a ISIL_DE-M477 | ||
912 | |a GBV_ILN_702 | ||
912 | |a ISIL_DE-B2226 | ||
912 | |a GBV_ILN_752 | ||
912 | |a ISIL_DE-Y4 | ||
912 | |a GBV_ILN_754 | ||
912 | |a ISIL_DE-B1532 | ||
912 | |a GBV_ILN_1200 | ||
912 | |a ISIL_DE-628 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a ISIL_DE-21 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a ISIL_DE-25 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a ISIL_DE-291 | ||
912 | |a GBV_ILN_2190 | ||
912 | |a ISIL_DE-Sa18 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a ISIL_DE-4 | ||
912 | |a GBV_ILN_4038 | ||
912 | |a ISIL_DE-77 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a ISIL_DE-29 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a ISIL_DE-355 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a ISIL_DE-19 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a ISIL_DE-20 | ||
951 | |a JT | ||
980 | |2 20 |1 01 |x 84/5555 |b 1870002466 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |g Bestand: lizenziert: 10.2010 - |h OLR-EZB |y b |z 11-03-19 | ||
980 | |2 22 |1 01 |x 18/5555 |b 3533795772 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |g Bestand: lizenziert: 10.2010 - |h olr-ezb |y bu |z 31-10-19 | ||
980 | |2 31 |1 01 |x 0027 |b 358244452X |g Bestand: lizenziert: 6.2006,1 - 19.2019,8 |y bezb |z 25-01-20 | ||
980 | |2 55 |1 01 |x 3055 |b 1368166148 |h OLR-EZB |y b |z 22-02-13 | ||
980 | |2 65 |1 01 |x 0003 |b 3852976715 |c 00 |f --%%-- |d --%%-- |e g |j --%%-- |g Bestand: lizenziert: 10.2010 - |h OLR-EZB |y b |z 13-02-21 | ||
980 | |2 65 |1 02 |x 0003 |b 4036152998 |c 00 |f --%%-- |d --%%-- |e g |j --%%-- |g Bestand: lizenziert: 6.2006 - |h OLR-EZB |y b |z 14-01-22 | ||
980 | |2 69 |1 01 |x 0009 |b 4195236002 |c 00 |f --%%-- |d --%%-- |e g |j --%%-- |g Bestand: lizenziert: 6.2006,1 - |h OLR-EZB |y b |z 08-10-22 | ||
980 | |2 209 |1 01 |x 3570 |b 123073709X |h OLR-EZB |y b |z 03-03-11 | ||
980 | |2 215 |1 01 |x 3215 |b 1441771085 |h OLR-EZB |y bezb |z 22-10-13 | ||
980 | |2 239 |1 01 |x 3239 |b 128465009X |h OLR-EZB |y bezb |z 26-12-11 | ||
980 | |2 685 |1 01 |x 4685 |b 3531393170 |y b |z 30-10-19 | ||
980 | |2 702 |1 01 |x 3714/0001 |b 1706167180 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |g Bestand: lizenziert: 6.2006,1 - 8.2008,4 |h OLR-EZB |y bk |z 05-08-17 | ||
980 | |2 752 |1 01 |x 4752 |b 3532225859 |y bezb |z 30-10-19 | ||
980 | |2 754 |1 01 |x 3754 |b 1266608931 |h OLR-EZB |y b |z 25-08-11 | ||
980 | |2 1200 |1 01 |x 0628 |b 1867985837 |c 00 |f FID-PHARM |d --%%-- |e --%%-- |j --%%-- |g Bestand: 10.2010- |y b |z 27-02-19 | ||
980 | |2 2001 |1 01 |x DE-21 |b 3479496717 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |g Bestand: 2010 - |y zez |z 04-05-19 | ||
980 | |2 2003 |1 01 |x DE-25 |b 3515897003 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |g Bestand: 10.2010 - |y zez |z 06-09-19 | ||
980 | |2 2005 |1 01 |x DE-291 |b 3857434082 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |g Bestand: 2010 - |y zez |z 02-02-21 | ||
980 | |2 2190 |1 01 |x DE-Sa18 |b 2775364306 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |g Bestand: 6.2006,1 - 8.2008,4 |y zez |z 30-10-18 | ||
980 | |2 4035 |1 01 |x 40000 |b 3608292403 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |g Bestand: 10.2010 - |y b |z 29-02-20 | ||
980 | |2 4035 |1 02 |x 40000 |b 4361680523 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |y b |z 24-07-23 | ||
980 | |2 4038 |1 01 |x 40035 |b 4169951069 |c 00 |f --%%-- |d --%%-- |e i |j --%%-- |y b |z 12-07-22 | ||
980 | |2 4112 |1 01 |x 40009 |b 3585371841 |g Bestand: 10.2010 - |y b |z 23-01-20 | ||
980 | |2 4125 |1 01 |x 40057 |b 347518981X |g Bestand: 10.2010 - |y b000 |z 01-03-19 | ||
980 | |2 4305 |1 01 |x 40006 |b 4022457376 |g Bestand: 10.2010 - |k The licensee may supply to a user of another library (whether by post, fax or secure electronic transmission, whereby the electronic file is deleted immediately after printing) a single copy of an electronic original of an individual document. |y bn |z 19-11-21 | ||
980 | |2 4305 |1 02 |x 40006 |b 4140379790 |g Bestand: 10.2010 - |k The licensee may supply to a user of another library (whether by post, fax or secure electronic transmission, whereby the electronic file is deleted immediately after printing) a single copy of an electronic original of an individual document. |y bn |z 29-04-22 | ||
980 | |2 4306 |1 01 |x 40007 |b 3663933350 |g Bestand: 2010 - |k Keine Fernleihe möglich! |y b |z 23-04-20 | ||
981 | |2 20 |1 00 |x DE-84 |r http://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=TUBS | ||
981 | |2 22 |1 00 |x DE-18 |y EZB |r http://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=SUBHH | ||
981 | |2 31 |1 00 |x DE-27 |y EZB |r http://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=THULB | ||
981 | |2 55 |1 01 |x 3055 |r https://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=MPIMD | ||
981 | |2 65 |1 00 |x DE-3 |r http://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=ULBH | ||
981 | |2 69 |1 00 |x DE-9 |r http://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=UBGRW | ||
981 | |2 209 |1 01 |x 3570 |r http://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=MPIL | ||
981 | |2 215 |1 01 |x 3215 |r http://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=MPIDS | ||
981 | |2 239 |1 01 |x 3239 |r http://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=ICE | ||
981 | |2 685 |1 01 |x 4685 |r http://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=MPISR | ||
981 | |2 702 |1 00 |x DE-B2226 |y EZB |r http://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=MPIWG | ||
981 | |2 752 |1 01 |x 4752 |r http://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=MPIPL | ||
981 | |2 754 |1 01 |x 3754 |r http://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=MPIBF | ||
981 | |2 1200 |1 01 |x 0628 |y Zugriff nur für berechtigte Nutzer des FID |r http://pharmazie.proxy.fid-lizenzen.de/fid/bentham-ejournals-pharmazie/www.eurekaselect.com/636/journal/endocrine-metabolic-amp-immune-disorders-drug-targets | ||
981 | |2 1200 |1 01 |x 0628 |y Registrierungslink |r http://pharmazie.fid-lizenzen.de/kfllogin | ||
981 | |2 2001 |1 01 |x DE-21 |r https://ezb.ur.de/detail.phtml?bibid=UBTUE&jour_id=88528 | ||
981 | |2 2003 |1 01 |x DE-25 |r https://ezb.ur.de/detail.phtml?bibid=UBFRE&jour_id=88528 | ||
981 | |2 2005 |1 01 |x DE-291 |r https://ezb.ur.de/detail.phtml?bibid=SULB&jour_id=88528 | ||
981 | |2 2190 |1 01 |x DE-Sa18 |r https://ezb.ur.de/detail.phtml?bibid=MPII&jour_id=88528 | ||
981 | |2 2190 |1 01 |x DE-Sa18 |r https://ezb.ur.de/ReadMe?bibid=MPII&owner=MPG&anchor=bentham&lang=de | ||
981 | |2 2190 |1 01 |x DE-Sa18 |r https://ezb.ur.de/ReadMe?bibid=MPII&owner=MPG&anchor=bentham&lang=en | ||
981 | |2 2190 |1 01 |x DE-Sa18 |r http://www.eurekaselect.com/636/journal/endocrine-metabolic-amp-immune-disorders-drug-targets | ||
981 | |2 4035 |1 01 |x 40000 |r https://ezb.ur.de/detail.phtml?bibid=UBMA&jour_id=88528 | ||
981 | |2 4035 |1 01 |x 40000 |r https://ezb.ur.de/ReadMe?bibid=UBMA&owner=UBMA&anchor=fid_pharm&lang=de | ||
981 | |2 4035 |1 01 |x 40000 |r https://ezb.ur.de/ReadMe?bibid=UBMA&owner=UBMA&anchor=fid_pharm&lang=en | ||
981 | |2 4035 |1 01 |x 40000 |r http://www.eurekaselect.com/636/journal/endocrine-metabolic-amp-immune-disorders-drug-targets | ||
981 | |2 4035 |1 02 |x 40000 |r http://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=UBMA | ||
981 | |2 4038 |1 01 |x 40035 |r http://www.bibliothek.uni-regensburg.de/ezeit/?2254157&bibid=UBMZ | ||
981 | |2 4112 |1 01 |x 40009 |r https://ezb.ur.de/detail.phtml?bibid=UBEN&jour_id=88528 | ||
981 | |2 4112 |1 01 |x 40009 |r https://ezb.ur.de/ReadMe?bibid=UBEN&owner=UBEN&anchor=fid_pharmazie&lang=de | ||
981 | |2 4112 |1 01 |x 40009 |r https://ezb.ur.de/ReadMe?bibid=UBEN&owner=UBEN&anchor=fid_pharmazie&lang=en | ||
981 | |2 4112 |1 01 |x 40009 |r http://www-1eurekaselect-1com-1tehaujns07bf.proxy.fid-lizenzen.de/636/journal/endocrine-metabolic-amp-immune-disorders-drug-targets | ||
981 | |2 4125 |1 01 |x 40057 |r https://ezb.ur.de/detail.phtml?bibid=UBR&jour_id=88528 | ||
981 | |2 4125 |1 01 |x 40057 |r https://ezb.ur.de/ReadMe?bibid=UBR&owner=UBR&anchor=fid_bentham&lang=de | ||
981 | |2 4125 |1 01 |x 40057 |r https://ezb.ur.de/ReadMe?bibid=UBR&owner=UBR&anchor=fid_bentham&lang=en | ||
981 | |2 4125 |1 01 |x 40057 |r https://www.eurekaselect.com/636/journal/endocrine-metabolic-amp-immune-disorders-drug-targets | ||
981 | |2 4305 |1 01 |x 40006 |r https://ezb.ur.de/detail.phtml?bibid=UBM&jour_id=88528 | ||
981 | |2 4305 |1 01 |x 40006 |r https://ezb.ur.de/ReadMe?bibid=UBM&owner=UBM&anchor=FID_Pharmazie_Bentham&lang=de | ||
981 | |2 4305 |1 01 |x 40006 |r https://ezb.ur.de/ReadMe?bibid=UBM&owner=UBM&anchor=FID_Pharmazie_Bentham&lang=en | ||
981 | |2 4305 |1 01 |x 40006 |r https://www.eurekaselect.com/636/journal/endocrine-metabolic-amp-immune-disorders-drug-targets | ||
981 | |2 4305 |1 02 |x 40006 |r https://ezb.ur.de/detail.phtml?bibid=UBM&jour_id=88528 | ||
981 | |2 4305 |1 02 |x 40006 |r https://ezb.ur.de/ReadMe?bibid=UBM&owner=UBM&anchor=FID_Pharmazie_Bentham&lang=de | ||
981 | |2 4305 |1 02 |x 40006 |r https://ezb.ur.de/ReadMe?bibid=UBM&owner=UBM&anchor=FID_Pharmazie_Bentham&lang=en | ||
981 | |2 4305 |1 02 |x 40006 |r http://www.ingentaconnect.com/content/ben/emiddt | ||
981 | |2 4306 |1 01 |x 40007 |r https://ezb.ur.de/detail.phtml?bibid=UBW&jour_id=88528 | ||
981 | |2 4306 |1 01 |x 40007 |r https://ezb.ur.de/ReadMe?bibid=UBW&owner=UBW&anchor=fid_pharmazie&lang=de | ||
981 | |2 4306 |1 01 |x 40007 |r https://ezb.ur.de/ReadMe?bibid=UBW&owner=UBW&anchor=fid_pharmazie&lang=en | ||
981 | |2 4306 |1 01 |x 40007 |r https://www-eurekaselect-com.fid-pharmazie.idm.oclc.org/journal/59 | ||
985 | |2 1200 |1 01 |x 0628 |a prod_DARH_02 | ||
987 | |2 20 |1 01 |x 84/5555 |d 10 |j 2010 |6 | ||
987 | |2 22 |1 01 |x 18/5555 |d 10 |j 2010 |6 | ||
987 | |2 31 |1 01 |x 0027 |d 6 |e 1 |j 2006 |n 19 |o 8 |k 2019 | ||
987 | |2 65 |1 01 |x 0003 |d 10 |j 2010 |6 | ||
987 | |2 65 |1 02 |x 0003 |d 6 |j 2006 |6 | ||
987 | |2 69 |1 01 |x 0009 |d 6 |e 1 |j 2006 |6 | ||
987 | |2 702 |1 01 |x 3714/0001 |d 6 |e 1 |j 2006 |n 8 |o 4 |k 2008 | ||
987 | |2 1200 |1 01 |x 0628 |d 10 |j 2010 |6 | ||
987 | |2 2001 |1 01 |x DE-21 |j 2010 |6 | ||
987 | |2 2003 |1 01 |x DE-25 |d 10 |j 2010 |6 | ||
987 | |2 2005 |1 01 |x DE-291 |j 2010 |6 | ||
987 | |2 2190 |1 01 |x DE-Sa18 |d 6 |e 1 |j 2006 |n 8 |o 4 |k 2008 | ||
987 | |2 4035 |1 01 |x 40000 |d 10 |j 2010 |6 | ||
987 | |2 4112 |1 01 |x 40009 |d 10 |j 2010 |6 | ||
987 | |2 4125 |1 01 |x 40057 |d 10 |j 2010 |6 | ||
987 | |2 4305 |1 01 |x 40006 |d 10 |j 2010 |6 | ||
987 | |2 4305 |1 02 |x 40006 |d 10 |j 2010 |6 | ||
987 | |2 4306 |1 01 |x 40007 |j 2010 |6 | ||
995 | |2 20 |1 01 |x 84/5555 |a OLR-EZB | ||
995 | |2 22 |1 01 |x 18/5555 |a olr-ezb | ||
995 | |2 55 |1 01 |x 3055 |a OLR-EZB | ||
995 | |2 65 |1 01 |x 0003 |a OLR-EZB | ||
995 | |2 65 |1 02 |x 0003 |a OLR-EZB | ||
995 | |2 69 |1 01 |x 0009 |a OLR-EZB | ||
995 | |2 209 |1 01 |x 3570 |a OLR-EZB | ||
995 | |2 215 |1 01 |x 3215 |a OLR-EZB | ||
995 | |2 239 |1 01 |x 3239 |a OLR-EZB | ||
995 | |2 702 |1 01 |x 3714/0001 |a OLR-EZB | ||
995 | |2 754 |1 01 |x 3754 |a OLR-EZB |